PF-06726304 acetate iglurax Smiles: CC(C)N1C=C(C2=CC=NC(NC[C@H](C)NC(=O)OC)=N2)C(=N1)C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F

Smiles: CC(C)N1C=C(C2=CC=NC(NC[C@H](C)NC(=O)OC)=N2)C(=N1)C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F

InChi: InChI=1S/C22H22ClN5O2

InChi: InChI=1S/C16H18O7/c1-7-16(21)14(20)12-9(3-2-4-10(12)17)13(19)15(16)6-8(22-7)5-11(18)23-15/h2-4

Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells

6-48 hours) results in a remarkably time- and dose-dependent decrease in Cdc2 and Cdc25C expression levels and increases cyclin B1 within 6h

PF-06726304 acetate iglurax Smiles: CC(C)N1C=C(C2=CC=NC(NC[C@H](C)NC(=O)OC)=N2)C(=N1)C1=CC(Cl)=CC(NS(C)(=O)=O)=C1FPF 06726304 acetate is a potent and selective EZH2 inhibitor. PF 06726304 acetate inhibits wild type and Y641N mutant EZH2 with Kis of 0. 7 and 3. 0 nM, respectively. PF 06726304 acetate displays robust antitumor growth activity. Product information CAS Number: 2080306 28 9 Molecular Weight: 506. 38 Formula: C24H25Cl2N3O5 Chemical Name: 5,8 dichloro 7 (3,5 dimethyl 1,2 oxazol 4 yl) 2 [(4,6 dimethyl 2 oxo 1,2 dihydropyridin 3 yl)methyl] 1,2,3,4